Future studies exploring the role of S100A9 as well as other alarmins in cancer is of great importance for the development of new therapeutics aimed at tuning the anti-tumor immune response and for understanding the resistance mechanisms to current treatments such as checkpoint inhibition (50). Here, S100A9 is linked to cancer.